Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention

Background: Atypical memory B (AMB) is a novel subset of B lymphocytes, but its immune features and pathogenetic roles in systemic rheumatic diseases are still largely elusive. This study aimed to characterize transcriptomic features, immune phenotypes and potential signaling pathways of AMB, and al...

Full description

Saved in:
Bibliographic Details
Main Authors: Fuli Fan, Shubei Liu, Bin Wang, Xiaojian Song, Wei Wang
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Immunobiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0171298525000117
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856910310309888
author Fuli Fan
Shubei Liu
Bin Wang
Xiaojian Song
Wei Wang
author_facet Fuli Fan
Shubei Liu
Bin Wang
Xiaojian Song
Wei Wang
author_sort Fuli Fan
collection DOAJ
description Background: Atypical memory B (AMB) is a novel subset of B lymphocytes, but its immune features and pathogenetic roles in systemic rheumatic diseases are still largely elusive. This study aimed to characterize transcriptomic features, immune phenotypes and potential signaling pathways of AMB, and also to confirm its alternations in systemic rheumatic diseases via combined transcriptome analyses. Method: B cell subsets and their transcriptomic signatures were identified via analyses of single cell RNA-sequencing (scRNA-seq) data. Functional characterization of AMB was performed with bioinformatics and CyTOF-based phenotyping. Alternation of AMB in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Sjögren's syndrome (SjS) was evaluated via bioinformatic approaches. Result: A total of 11 B cell subsets including AMB were identified through scRNA-seq transcriptome analyses. Both transcriptome analyses and CyTOF-based immune phenotyping confirmed that AMB had increased levels of TBX21 (T-bet), ITGAX (CD11c), CD19, CD20 and CXCR3 (P < 0.05), and it had decreased expressions of CD27, CD38, CXCR4, CXCR5 and CD62L (P < 0.05). More than 50 % of T-bet+ B cells did not express CD11c, and more than 30 % expressed CD27. AMB was characterized by activated mTORC1 signaling and increased p-P38 level (P < 0.05). AMB transcriptional signature was significantly enriched in the peripheral blood and disease tissues of patients of SLE, RA and SjS (P < 0.05), suggesting the expanded AMB cells in those patients. Conclusion: This study defines the transcriptomic signature, immune phenotypes and potential signaling pathways of AMB, and also confirms the involvement of AMB in systemic rheumatic diseases including SLE, RA and SjS via transcriptomic approaches. mTORC1 signaling and P38/MAPK signaling are promising therapeutic targets for systemic rheumatic diseases mediated by AMB.
format Article
id doaj-art-72c5c914f75b4d3c80a1f038b77f541b
institution Kabale University
issn 0171-2985
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Immunobiology
spelling doaj-art-72c5c914f75b4d3c80a1f038b77f541b2025-02-12T05:30:23ZengElsevierImmunobiology0171-29852025-03-012302152877Integrated analyses uncover new features of atypical memory B cells and novel targets for interventionFuli Fan0Shubei Liu1Bin Wang2Xiaojian Song3Wei Wang4Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, ChinaDepartment of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, ChinaCentral Laboratory, Weifang People's Hospital, Shandong Second Medical University, Weifang 261000, China; Department of Traumatology and Orthopaedics, Weifang People's Hospital, Shandong Second Medical University, Weifang 261000, China; Corresponding author at: Department of Traumatology and Orthopaedics, Weifang People's Hospital, Shandong Second Medical University, Weifang 261000, China.Weiriver Novel Research Association, Weifang 262212, ChinaDepartment of Hematology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, China; Corresponding author.Background: Atypical memory B (AMB) is a novel subset of B lymphocytes, but its immune features and pathogenetic roles in systemic rheumatic diseases are still largely elusive. This study aimed to characterize transcriptomic features, immune phenotypes and potential signaling pathways of AMB, and also to confirm its alternations in systemic rheumatic diseases via combined transcriptome analyses. Method: B cell subsets and their transcriptomic signatures were identified via analyses of single cell RNA-sequencing (scRNA-seq) data. Functional characterization of AMB was performed with bioinformatics and CyTOF-based phenotyping. Alternation of AMB in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Sjögren's syndrome (SjS) was evaluated via bioinformatic approaches. Result: A total of 11 B cell subsets including AMB were identified through scRNA-seq transcriptome analyses. Both transcriptome analyses and CyTOF-based immune phenotyping confirmed that AMB had increased levels of TBX21 (T-bet), ITGAX (CD11c), CD19, CD20 and CXCR3 (P < 0.05), and it had decreased expressions of CD27, CD38, CXCR4, CXCR5 and CD62L (P < 0.05). More than 50 % of T-bet+ B cells did not express CD11c, and more than 30 % expressed CD27. AMB was characterized by activated mTORC1 signaling and increased p-P38 level (P < 0.05). AMB transcriptional signature was significantly enriched in the peripheral blood and disease tissues of patients of SLE, RA and SjS (P < 0.05), suggesting the expanded AMB cells in those patients. Conclusion: This study defines the transcriptomic signature, immune phenotypes and potential signaling pathways of AMB, and also confirms the involvement of AMB in systemic rheumatic diseases including SLE, RA and SjS via transcriptomic approaches. mTORC1 signaling and P38/MAPK signaling are promising therapeutic targets for systemic rheumatic diseases mediated by AMB.http://www.sciencedirect.com/science/article/pii/S0171298525000117Atypical memory B cellsSystemic rheumatic diseasesSingle cell RNA-sequencingTreatment targets
spellingShingle Fuli Fan
Shubei Liu
Bin Wang
Xiaojian Song
Wei Wang
Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
Immunobiology
Atypical memory B cells
Systemic rheumatic diseases
Single cell RNA-sequencing
Treatment targets
title Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
title_full Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
title_fullStr Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
title_full_unstemmed Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
title_short Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
title_sort integrated analyses uncover new features of atypical memory b cells and novel targets for intervention
topic Atypical memory B cells
Systemic rheumatic diseases
Single cell RNA-sequencing
Treatment targets
url http://www.sciencedirect.com/science/article/pii/S0171298525000117
work_keys_str_mv AT fulifan integratedanalysesuncovernewfeaturesofatypicalmemorybcellsandnoveltargetsforintervention
AT shubeiliu integratedanalysesuncovernewfeaturesofatypicalmemorybcellsandnoveltargetsforintervention
AT binwang integratedanalysesuncovernewfeaturesofatypicalmemorybcellsandnoveltargetsforintervention
AT xiaojiansong integratedanalysesuncovernewfeaturesofatypicalmemorybcellsandnoveltargetsforintervention
AT weiwang integratedanalysesuncovernewfeaturesofatypicalmemorybcellsandnoveltargetsforintervention